KKL-35 Exhibits Potent Antibiotic Activity against Legionella Species Independently of trans -Translation Inhibition
Open Access
- 1 February 2018
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (2) , e01459-17
Abstract
trans -Translation is a ribosome-rescue system that is ubiquitous in bacteria. Small molecules defining a new family of oxadiazole compounds that inhibit trans -translation have been found to have broad-spectrum antibiotic activity. We sought to determine the activity of KKL-35, a potent member of the oxadiazole family, against the human pathogen Legionella pneumophila and other related species that can also cause Legionnaires' disease (LD). Consistent with the essential nature of trans -translation in L. pneumophila , KKL-35 inhibited the growth of all tested strains at submicromolar concentrations. KKL-35 was also active against other LD-causing Legionella species. KKL-35 remained equally active against L. pneumophila mutants that have evolved resistance to macrolides. KKL-35 inhibited the multiplication of L. pneumophila in human macrophages at several stages of infection. No resistant mutants could be obtained, even during extended and chronic exposure. Surprisingly, KKL-35 was not synergistic with other ribosome-targeting antibiotics and did not induce the filamentation phenotype observed in cells defective for trans -translation. Importantly, KKL-35 remained active against L. pneumophila mutants expressing an alternate ribosome-rescue system and lacking transfer-messenger RNA, the essential component of trans -translation. These results indicate that the antibiotic activity of KKL-35 is not related to the specific inhibition of trans -translation and its mode of action remains to be identified. In conclusion, KKL-35 is an effective antibacterial agent against the intracellular pathogen L. pneumophila with no detectable resistance development. However, further studies are needed to better understand its mechanism of action and to assess further the potential of oxadiazoles in treatment.Keywords
All Related Versions
Funding Information
- European Society of Clinical Microbiology and Infectious Diseases (Research Grant 2015)
- Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche (Allocation de thèse)
This publication has 45 references indexed in Scilit:
- Guidelines for the management of adult lower respiratory tract infections - Full versionClinical Microbiology and Infection, 2011
- Escherichia coli YaeJ protein mediates a novel ribosome‐rescue pathway distinct from SsrA‐ and ArfA‐mediated pathwaysMolecular Microbiology, 2011
- YaeJ is a novel ribosome-associated protein in Escherichia coli that can hydrolyze peptidyl-tRNA on stalled ribosomesNucleic Acids Research, 2010
- Ribosome rescue by Escherichia coli ArfA (YhdL) in the absence of trans-translation systemMolecular Microbiology, 2010
- The metal efflux island ofLegionella pneumophilais not required for survival in macrophages and amoebasFEMS Microbiology Letters, 2009
- Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophilaJournal of Antimicrobial Chemotherapy, 2009
- Biology of trans-TranslationAnnual Review of Microbiology, 2008
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- RNase R degrades non‐stop mRNAs selectively in an SmpB‐tmRNA‐dependent mannerMolecular Microbiology, 2006
- Synergy, antagonism, and what the chequerboard puts between themJournal of Antimicrobial Chemotherapy, 2003